Accounts Payable (Quarterly) Chart

View Accounts Payable (Quarterly) for RVP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Accounts Payable (Quarterly) Chart
Start Trial

Historical Accounts Payable (Quarterly) Data

View and export this data back to 1999. Start Trial.
Date Value
March 31, 2026 5.384M
December 31, 2025 5.340M
September 30, 2025 4.575M
June 30, 2025 4.060M
March 31, 2025 4.724M
December 31, 2024 4.291M
September 30, 2024 3.251M
June 30, 2024 3.114M
March 31, 2024 2.594M
December 31, 2023 4.779M
September 30, 2023 3.393M
June 30, 2023 3.581M
March 31, 2023 5.371M
December 31, 2022 6.405M
September 30, 2022 8.133M
June 30, 2022 9.288M
March 31, 2022 13.29M
December 31, 2021 20.40M
September 30, 2021 24.41M
June 30, 2021 30.25M
March 31, 2021 14.30M
December 31, 2020 16.26M
September 30, 2020 7.280M
June 30, 2020 7.190M
March 31, 2020 4.435M
Date Value
December 31, 2019 5.008M
September 30, 2019 5.687M
June 30, 2019 5.054M
March 31, 2019 4.847M
December 31, 2018 5.370M
September 30, 2018 4.908M
June 30, 2018 4.802M
March 31, 2018 4.260M
December 31, 2017 4.958M
September 30, 2017 5.046M
June 30, 2017 4.446M
March 31, 2017 4.461M
December 31, 2016 4.472M
September 30, 2016 4.709M
June 30, 2016 5.020M
March 31, 2016 4.369M
December 31, 2015 5.698M
September 30, 2015 5.106M
June 30, 2015 4.308M
March 31, 2015 4.954M
December 31, 2014 5.143M
September 30, 2014 6.021M
June 30, 2014 4.807M
March 31, 2014 3.846M
December 31, 2013 5.108M

Accounts Payable Definition

Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.

Read full definition.

Accounts Payable (Quarterly) Range, Past 5 Years

View Accounts Payable (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Accounts Payable (Quarterly) Benchmarks

View Accounts Payable (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 4.679B
AngioDynamics, Inc. 29.10M
Alphatec Holdings, Inc. 46.04M
AtriCure, Inc. 30.56M
Baxter International, Inc. 1.086B